Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Apr 1;181(4):1539–1550. doi: 10.1084/jem.181.4.1539

Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice

PMCID: PMC2191969  PMID: 7535341

Abstract

Tumor dormancy can be induced in a murine B cell lymphoma (BCL1) by immunizing BALB/c mice with the tumor immunoglobulin (Ig) before tumor cell challenge. In this report, we have investigated the immunological and cellular mechanisms underlying the induction of dormancy. BCL1 tumor cells were injected into SCID mice passively immunized with antibody against different epitopes on IgM or IgD with or without idiotype (Id)-immune T lymphocytes. Results indicate that antibody to IgM is sufficient to induce a state of dormancy. Antibodies against other cell surface molecules including IgD and CD44 (Pgp1) had no effect on tumor growth. Id-immune T cells by themselves also had no effect on tumor growth in SCID mice. However, simultaneous transfer of anti-Id and Id-immune T cells enhanced both the induction and duration of the dormant state. In vitro studies indicated that antibody to IgM induced apoptosis within several hours and cell cycle arrest by 24 h. Hyper cross-linking increased apoptosis. The Fc gamma RII receptor played little or no role in the negative signaling. Antibodies that did not negatively signal in vitro did not induce dormancy in vivo. The results suggest that anti-IgM plays a decisive role in inducing tumor dormancy to BCL1 by acting as an agonist of IgM-mediated signal transduction pathways.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baixeras E., Kroemer G., Cuende E., Márquez C., Boscá L., Alés Martínez J. E., Martínez C. Signal transduction pathways involved in B-cell induction. Immunol Rev. 1993 Apr;132:5–47. doi: 10.1111/j.1600-065x.1993.tb00836.x. [DOI] [PubMed] [Google Scholar]
  2. Bosma M. J., Carroll A. M. The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol. 1991;9:323–350. doi: 10.1146/annurev.iy.09.040191.001543. [DOI] [PubMed] [Google Scholar]
  3. Brink R., Goodnow C. C., Crosbie J., Adams E., Eris J., Mason D. Y., Hartley S. B., Basten A. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med. 1992 Oct 1;176(4):991–1005. doi: 10.1084/jem.176.4.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brooks K., Yuan D., Uhr J. W., Krammer P. H., Vitetta E. S. Lymphokine-induced IgM secretion by clones of neoplastic B cells. Nature. 1983 Apr 28;302(5911):825–826. doi: 10.1038/302825a0. [DOI] [PubMed] [Google Scholar]
  5. Cambier J. C., Pleiman C. M., Clark M. R. Signal transduction by the B cell antigen receptor and its coreceptors. Annu Rev Immunol. 1994;12:457–486. doi: 10.1146/annurev.iy.12.040194.002325. [DOI] [PubMed] [Google Scholar]
  6. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M. A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 1992;13(8):795–808. doi: 10.1002/cyto.990130802. [DOI] [PubMed] [Google Scholar]
  7. Dorshkind K., Pollack S. B., Bosma M. J., Phillips R. A. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol. 1985 Jun;134(6):3798–3801. [PubMed] [Google Scholar]
  8. Duke R. C., Chervenak R., Cohen J. J. Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis. Proc Natl Acad Sci U S A. 1983 Oct;80(20):6361–6365. doi: 10.1073/pnas.80.20.6361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Durandy A., Brousse N., Rozenberg F., De Saint Basile G., Fischer A. M., Fischer A. Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J Clin Invest. 1992 Sep;90(3):945–952. doi: 10.1172/JCI115971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dyer M. J., Hale G., Hayhoe F. G., Waldmann H. Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood. 1989 May 1;73(6):1431–1439. [PubMed] [Google Scholar]
  11. Feldmann M. Induction of immunity and tolerance in vitro by hapten protein conjugates. I. The relationship between the degree of hapten conjugation and the immunogenicity of dinitrophenylated polymerized flagellin. J Exp Med. 1972 Apr 1;135(4):735–753. doi: 10.1084/jem.135.4.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fischer A., Blanche S., Le Bidois J., Bordigoni P., Garnier J. L., Niaudet P., Morinet F., Le Deist F., Fischer A. M., Griscelli C. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med. 1991 May 23;324(21):1451–1456. doi: 10.1056/NEJM199105233242102. [DOI] [PubMed] [Google Scholar]
  13. Fischer G., Kent S. C., Joseph L., Green D. R., Scott D. W. Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. J Exp Med. 1994 Jan 1;179(1):221–228. doi: 10.1084/jem.179.1.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Funakoshi S., Longo D. L., Beckwith M., Conley D. K., Tsarfaty G., Tsarfaty I., Armitage R. J., Fanslow W. C., Spriggs M. K., Murphy W. J. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood. 1994 May 15;83(10):2787–2794. [PubMed] [Google Scholar]
  15. Gaur A., Yao X. R., Scott D. W. B cell tolerance induction by cross-linking of membrane IgM, but not IgD, and synergy by cross-linking of both isotypes. J Immunol. 1993 Mar 1;150(5):1663–1669. [PubMed] [Google Scholar]
  16. George A. J., Folkard S. G., Hamblin T. J., Stevenson F. K. Idiotypic vaccination as a treatment for a B cell lymphoma. J Immunol. 1988 Sep 15;141(6):2168–2174. [PubMed] [Google Scholar]
  17. George A. J., Tutt A. L., Stevenson F. K. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1. J Immunol. 1987 Jan 15;138(2):628–634. [PubMed] [Google Scholar]
  18. Ghetie M. A., Picker L. J., Richardson J. A., Tucker K., Uhr J. W., Vitetta E. S. Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest. Blood. 1994 Mar 1;83(5):1329–1336. [PubMed] [Google Scholar]
  19. Hasbold J., Klaus G. G. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur J Immunol. 1990 Aug;20(8):1685–1690. doi: 10.1002/eji.1830200810. [DOI] [PubMed] [Google Scholar]
  20. Heath A. W., Chang R., Harada N., Santos-Argumedo L., Gordon J., Hannum C., Campbell D., Shanafelt A. B., Clark E. A., Torres R. Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cells. Cell Immunol. 1993 Dec;152(2):468–480. doi: 10.1006/cimm.1993.1305. [DOI] [PubMed] [Google Scholar]
  21. Herlyn D., Herlyn M., Steplewski Z., Koprowski H. Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells. Cell Immunol. 1985 Apr 15;92(1):105–114. doi: 10.1016/0008-8749(85)90068-1. [DOI] [PubMed] [Google Scholar]
  22. Jakway J. P., Usinger W. R., Gold M. R., Mishell R. I., DeFranco A. L. Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products. J Immunol. 1986 Oct 1;137(7):2225–2231. [PubMed] [Google Scholar]
  23. Kamesaki H., Zwiebel J. A., Reed J. C., Cossman J. Role of bcl-2 and IL-5 in the regulation of anti-IgM-induced growth arrest and apoptosis in immature B cell lines. A cooperative regulation model for B cell clonal deletion. J Immunol. 1994 Apr 1;152(7):3294–3305. [PubMed] [Google Scholar]
  24. Kim K. M., Yoshimura T., Watanabe H., Ishigami T., Nambu M., Hata D., Higaki Y., Sasaki M., Tsutsui T., Mayumi M. Growth regulation of a human mature B cell line, B104, by anti-IgM and anti-IgD antibodies. J Immunol. 1991 Feb 1;146(3):819–825. [PubMed] [Google Scholar]
  25. Kroemer G., Martínez C. Clonal deletion, anergy and immunosuppression are connected in series to guarantee self-tolerance. Res Immunol. 1992 Mar-Apr;143(3):335–340. doi: 10.1016/s0923-2494(92)80133-6. [DOI] [PubMed] [Google Scholar]
  26. Krolick K. A., Villemez C., Isakson P., Uhr J. W., Vitetta E. S. Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5419–5423. doi: 10.1073/pnas.77.9.5419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kummer U., Staerz U. D. Concepts of antibody-mediated cancer therapy. Cancer Invest. 1993;11(2):174–184. doi: 10.3109/07357909309024836. [DOI] [PubMed] [Google Scholar]
  28. Oren R., Takahashi S., Doss C., Levy R., Levy S. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol. 1990 Aug;10(8):4007–4015. doi: 10.1128/mcb.10.8.4007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Owellen R. J., Donigian D. W., Hartke C. A., Dickerson R. M., Kuhar M. J. The binding of vinblastine to tubulin and to particulate fractions of mammalian brain. Cancer Res. 1974 Dec;34(12):3180–3186. [PubMed] [Google Scholar]
  30. Page D. M., DeFranco A. L. Antigen receptor-induced cell cycle arrest in WEHI-231 B lymphoma cells depends on the duration of signaling before the G1 phase restriction point. Mol Cell Biol. 1990 Jun;10(6):3003–3012. doi: 10.1128/mcb.10.6.3003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Parry S. L., Hasbold J., Holman M., Klaus G. G. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol. 1994 Mar 15;152(6):2821–2829. [PubMed] [Google Scholar]
  32. Parry S. L., Holman M. J., Hasbold J., Klaus G. G. Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. Eur J Immunol. 1994 Apr;24(4):974–979. doi: 10.1002/eji.1830240429. [DOI] [PubMed] [Google Scholar]
  33. Peacock J. S., Barisas B. G. Photobleaching recovery studies of antigen-specific mouse lymphocyte stimulation by DNP-conjugated polymerized flagellin. J Immunol. 1981 Sep;127(3):900–906. [PubMed] [Google Scholar]
  34. Phillips N. E., Parker D. C. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol. 1984 Feb;132(2):627–632. [PubMed] [Google Scholar]
  35. Press O. W., Appelbaum F., Ledbetter J. A., Martin P. J., Zarling J., Kidd P., Thomas E. D. Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood. 1987 Feb;69(2):584–591. [PubMed] [Google Scholar]
  36. Scheuermann R. H., Racila E., Tucker T., Yefenof E., Street N. E., Vitetta E. S., Picker L. J., Uhr J. W. Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4048–4052. doi: 10.1073/pnas.91.9.4048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Scott D. W., Livnat D., Pennell C. A., Keng P. Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu. J Exp Med. 1986 Jul 1;164(1):156–164. doi: 10.1084/jem.164.1.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Scott D. W., Warner G. L., Yao X. R., Kent S. C. Pathways and regulation of B-cell responsiveness and tolerance. Chem Immunol. 1994;58:34–66. [PubMed] [Google Scholar]
  39. Shaw D. R., Khazaeli M. B., LoBuglio A. F. Mouse/human chimeric antibodies to a tumor-associated antigen: biologic activity of the four human IgG subclasses. J Natl Cancer Inst. 1988 Dec 7;80(19):1553–1559. doi: 10.1093/jnci/80.19.1553. [DOI] [PubMed] [Google Scholar]
  40. Sieckmann D. G. The use of anti-immunoglobulins to induce a signal for cell division in B lymphocytes via their membrane IgM and IgD. Immunol Rev. 1980;52:181–210. doi: 10.1111/j.1600-065x.1980.tb00335.x. [DOI] [PubMed] [Google Scholar]
  41. Slavin S., Strober S. Spontaneous murine B-cell leukaemia. Nature. 1978 Apr 13;272(5654):624–626. doi: 10.1038/272624a0. [DOI] [PubMed] [Google Scholar]
  42. Terstappen L. W., Mickaels R. A., Dost R., Loken M. R. Increased light scattering resolution facilitates multidimensional flow cytometric analysis. Cytometry. 1990;11(4):506–512. doi: 10.1002/cyto.990110409. [DOI] [PubMed] [Google Scholar]
  43. Uhr J. W., Tucker T., May R. D., Siu H., Vitetta E. S. Cancer dormancy: studies of the murine BCL1 lymphoma. Cancer Res. 1991 Sep 15;51(18 Suppl):5045s–5053s. [PubMed] [Google Scholar]
  44. Vitetta E. S., Yuan D., Krolick K., Isakson P., Knapp M., Slavin S., Strober S. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody. J Immunol. 1979 May;122(5):1649–1654. [PubMed] [Google Scholar]
  45. Vuist W. M., Levy R., Maloney D. G. Lymphoma regression induced by monoclonal anti-idiotypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of bcl-2 protein. Blood. 1994 Feb 15;83(4):899–906. [PubMed] [Google Scholar]
  46. Wiegel F. W., Perelson A. S. Configurations of a polymeric antigen adsorbed to a B-cell membrane. J Theor Biol. 1981 Feb 7;88(3):533–568. doi: 10.1016/0022-5193(81)90282-4. [DOI] [PubMed] [Google Scholar]
  47. Wilson H. A., Greenblatt D., Taylor C. W., Putney J. W., Tsien R. Y., Finkelman F. D., Chused T. M. The B lymphocyte calcium response to anti-Ig is diminished by membrane immunoglobulin cross-linkage to the Fc gamma receptor. J Immunol. 1987 Mar 15;138(6):1712–1718. [PubMed] [Google Scholar]
  48. Yagawa K., Vitetta E. S. Induction of proliferation and differentiation of murine B cells bearing surface Ig lambda by rat monoclonal antibody to lambda chain. Hybridoma. 1983;2(2):169–175. doi: 10.1089/hyb.1983.2.169. [DOI] [PubMed] [Google Scholar]
  49. Yao X. R., Scott D. W. Expression of protein tyrosine kinases in the Ig complex of anti-mu-sensitive and anti-mu-resistant B-cell lymphomas: role of the p55blk kinase in signaling growth arrest and apoptosis. Immunol Rev. 1993 Apr;132:163–186. doi: 10.1111/j.1600-065x.1993.tb00842.x. [DOI] [PubMed] [Google Scholar]
  50. Yefenof E., Picker L. J., Scheuermann R. H., Tucker T. F., Vitetta E. S., Uhr J. W. Cancer dormancy: isolation and characterization of dormant lymphoma cells. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1829–1833. doi: 10.1073/pnas.90.5.1829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Yellen-Shaw A., Monroe J. G. Differential responsiveness of immature- and mature-stage murine B cells to anti-IgM reflects both FcR-dependent and -independent mechanisms. Cell Immunol. 1992 Dec;145(2):339–350. doi: 10.1016/0008-8749(92)90336-n. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES